SCHEMBL19207883

SCHEMBL19207883

CC(=O)NC1COc2ccccc2N(C)C1=O

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19207881 1.00 RIPK1 (0.65) RIPK1
SCHEMBL3910591 0.89 RIPK1 (0.68) RIPK1
SCHEMBL3910585 0.89 RIPK1 (0.68) RIPK1
SCHEMBL31656042 0.87 RIPK1 (0.64) RIPK1
SCHEMBL19255334 0.83 RIPK1 (0.57) RIPK1
SCHEMBL12345835 0.83 RIPK1 (0.58) RIPK1
SCHEMBL31655905 0.83 RIPK1 (0.60) RIPK1
SCHEMBL14386223 0.83 RIPK1 (0.58) RIPK1
SCHEMBL20904076 0.80 RIPK1 (0.55) RIPK1
SCHEMBL31655944 0.80 RIPK1 (0.65) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
US-9896458-B2 Compounds, compositions and methods DENALI THERAPEUTICS INC. (US) 2018-02-20 US disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed